With the "graying of America" we are faced with the need to address the ever increasing number of individuals in our society who have age-associated nervous system diseases and conditions. It is estimated that by the year 2050, there will be up to 16 million Americans with Alzheimer's disease and an even larger number with additional nervous system-related diseases that are attributed to the aging of our population. To address this problem, we need multidisciplinary approaches to facilitate the discovery of the mechanisms, treatments and prevention of these diseases. Active, integrated research-based training of pre-doctoral students is a key to re- supplying the research personnel needed to address these biomedical health care issues. Herein we propose to continue a successful predoctoral program that focuses on the neurobiology of aging. The present application is a competing renewal of a very successful program of pre- and post-doctoral training at the University of North Texas Health Science Center (UNTHSC). This funding cycle we had 22 full fellows, of whom 10 completed their training and their Ph.D. and an additional 17 associate fellows for a total of 39 trainees in less than 5 years. Our trainees published 91 peer-reviewed papers;we trained 7 (of 22 = 32%) minority students as full fellows;6 (of 17 = 35%), for a total of 33% minority participation in our training program. The proposed training program will enhance an already strong and successful training program in the neurobiology of aging. The continuation of our predoctoral training program is proposed, as our Institute for Aging and Alzheimer's Disease Research (IAADR), founded by the Training Program Director, has matured through the addition of faculty and the funding of three program project grants, and has initiated clinical research into the causes, treatment and prevention of brain aging and Alzheimer's Disease at the UNTHSC. Collectively, our new training initiatives create a stimulating environment for the training of predoctoral trainees in the neurobiology of aging. Unique features of the training program are (1) our Associate Fellows program, which increases the number of trainees participating fully in the training program;(2) our emphasis on diversity training, that resulted in a 33% minority participation in the training program;(3) our high institutional support which is proposed to amount in an institutional commitment to the training program of approximately $276,800 over the next 5 years;(4) our focus on the development of research excellence and leadership among our trainees;and (5) our Preceptor-in-Training Program, which trains our more junior preceptors in pre-doctoral training. Collectively, these attributes of our Neurobiology of Aging Training Program have produced an outstanding program of training that we wish to continue.

Public Health Relevance

Training in the neurobiology of aging is proposed to address the ever increasing number of individuals in our society who have age-associated nervous system diseases and conditions. We propose to continue a successful predoctoral training program that focuses on diversity training, scientific excellence and leadership, and preparation of trainees for successful careers in the neurobiology of aging, through intensive research and research-related activities and publication of high quality research reports. A substantial institutional commitment to support this training program has been made to help ensure continued success of this program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Institutional National Research Service Award (T32)
Project #
2T32AG020494-11A1
Application #
8475271
Study Section
Special Emphasis Panel (ZAG1-ZIJ-3 (J1))
Program Officer
Wise, Bradley C
Project Start
2002-05-01
Project End
2018-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
11
Fiscal Year
2013
Total Cost
$317,182
Indirect Cost
$21,586
Name
University of North Texas
Department
Pharmacology
Type
Other Domestic Higher Education
DUNS #
110091808
City
Fort Worth
State
TX
Country
United States
Zip Code
76107
Rahimian, Pejman; He, Johnny J (2016) HIV-1 Tat-shortened neurite outgrowth through regulation of microRNA-132 and its target gene expression. J Neuroinflammation 13:247
Bermudez, Jaclyn Y; Webber, Hannah C; Patel, Gaurang C et al. (2016) HDAC Inhibitor-Mediated Epigenetic Regulation of Glaucoma-Associated TGFβ2 in the Trabecular Meshwork. Invest Ophthalmol Vis Sci 57:3698-707
Holmes, Shaletha; Singh, Meharvan; Su, Chang et al. (2016) Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell Line. Endocrinology 157:2824-35
Shah, Sunil; Chib, Rahul; Raut, Sangram et al. (2016) Photophysical characterization of anticancer drug valrubicin in rHDL nanoparticles and its use as an imaging agent. J Photochem Photobiol B 155:60-5
Silverman, Sean M; Kim, Byung-Jin; Howell, Garreth R et al. (2016) C1q propagates microglial activation and neurodegeneration in the visual axis following retinal ischemia/reperfusion injury. Mol Neurodegener 11:24
Rickards, Caroline A; Sprick, Justin D; Colby, Hannah B et al. (2015) Coupling between arterial pressure, cerebral blood velocity, and cerebral tissue oxygenation with spontaneous and forced oscillations. Physiol Meas 36:785-801
Choe, Katrina Y; Han, Su Y; Gaub, Perrine et al. (2015) High salt intake increases blood pressure via BDNF-mediated downregulation of KCC2 and impaired baroreflex inhibition of vasopressin neurons. Neuron 85:549-60
Coder, Brandon D; Wang, Hongjun; Ruan, Linhui et al. (2015) Thymic involution perturbs negative selection leading to autoreactive T cells that induce chronic inflammation. J Immunol 194:5825-37
Cherry, Brandon H; Nguyen, Anh Q; Hollrah, Roger A et al. (2015) Pyruvate stabilizes electrocardiographic and hemodynamic function in pigs recovering from cardiac arrest. Exp Biol Med (Maywood) 240:1774-84
Snell, Heather D; Gonzales, Eric B (2015) Amiloride and GMQ Allosteric Modulation of the GABA-A ρ1 Receptor: Influences of the Intersubunit Site. J Pharmacol Exp Ther 353:551-9

Showing the most recent 10 out of 56 publications